A neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who played in ...
A CHI Health neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who ...
Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...
BAYRY's experimental Parkinson's disease drug continues to show a favorable safety profile in all 12 participants in the ...
Rune Labs, a leader in precision medicine for Parkinson’s Disease (PD), today previewed the results of an ongoing nine-month ...
A new study has shown that unilateral deep brain stimulation (DBS) on the right side of the brain improves motor symptoms in ...
Parkinson's disease is a neurogenerative disorder that affects predominately the dopamine-producing (dopaminergic) neurons in the brain. People suffering from it face problems in motor movement, ...
More than 20 years later, Alberts and a team of researchers have received a $3 million, five-year award from the National ...
Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.
A question and answer session with Prof Suzanne Timmons, Professor of Geriatric Medicine at University College Cork ...
On Tuesday, former Packers football player, Brett Favre announced he suffers from Parkinson’s Disease. Parkinson’s Disease is a brain disorder that impacts ...
The following is a summary of “SGLT2 Inhibitor Use and Risk of Dementia and Parkinson’s Disease Among Patients With Type 2 ...